Overall , 282 patients were randomized to receive BDP-prolonged release tablets 5mg once daily for 4 weeks and then every other day for an additional 4 weeks or oral PD 40mg once daily for the initial 2 weeks tapered of 10mg every 2 weeks during the 8-week study period .